FDA Label for Hydrocortisone And Acetic Acid

View Indications, Usage & Precautions

Hydrocortisone And Acetic Acid Product Label

The following document was submitted to the FDA by the labeler of this product Cosette Pharmaceuticals, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Description



Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.05%), propylene glycol diacetate (3%) and sodium acetate (0.0025%). The empirical formulas for acetic acid and hydrocortisone are CH 3COOH, and C 21H 30O 5, with a molecular weight of 60.05 and 362.46, respectively.
The structural formulas are:

Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.


Clinical Pharmacology



Acetic acid is antibacterial and antifungal; hydrocortisone is anti-inflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.


Indications And Usage



For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.


Contraindications



Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.


Warnings



Discontinue promptly if sensitization or irritation occurs.


Precautions



Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.


Pediatric Use



Safety and effectiveness in pediatric patients below the age of 3 years have not been established.


Adverse Reactions



Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.


Dosage And Administration



Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.


How Supplied



Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles (NDC 0713-0849-09).


Storage



Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Keep container tightly closed.

Rx only

Distributed by:
Cosette Pharmaceuticals, Inc.
South Plainfield, NJ 07080

Rev. 12/2023
8-0849CPLNC1
VC7758


Package/Label Principal Display Panel



NDC 0713- 0849-09

Rx only

Hydrocortisone and Acetic Acid Otic Solution, USP

10 mL

Cosette Pharmaceuticals, Inc.

NDC 0713- 0849-09

Rx only

Hydrocortisone and Acetic Acid Otic Solution, USP

10 mL

Cosette Pharmaceuticals, Inc.


* Please review the disclaimer below.